The latest news, developments and research findings from all fields of science including biology, chemistry, physics, psychology, sociology and space, including news on the latest policies regulating this sector.
Brazilian scholars gain unprecedented access and collaboration opportunities with the ERC, reshaping research landscapes and hinting at transformative global impacts.
Here, Katri Huitu and Kenneth Österberg from the Helsinki Institute of Physics, Finland, discuss an important discovery of the Odderon and related activities of the Institute searching for the secrets of new particles and fundamental laws of Nature.
Here, Open Access Government charts the priorities of Japan’s Aerospace Exploration Agency (JAXA), and its work in scientific understanding and technological development towards sustainable human space exploration.
The World Health Organisation on Friday (18 June) said that the Delta variant, originating in India, would be globally dominant due to "significantly increased transmissibility".
Professor Dr Freimut Schliess, Director of Science & Innovation at the Profil Institut für Stoffwechselforschung GmbH, explores how the MDR will impact clinical trials.
Guangqing Chi and Junjun Yin from The Pennsylvania State University discuss how social media data has become a gold mine of information for both academic and non-academic use.
Senior Researcher Pierre-Olivier Lagage discusses how, after the detection of exoplanets, the characterisation of their atmosphere is the next step to understanding alien worlds.
Dr Carlos Ziebert, head of IAM-AWP’s Calorimeter Center, KIT, explains how the safety of batteries for electric cars can be increased by research using battery calorimeters.
Scientists tested makeup across the US and Canada for harmful chemicals - they found that over 75% of products tested contained PFAS, which are "forever chemicals".
Scientists reveal that billions of stars at the centre of the Milky Way are spinning more slowly - they believe it is being counterweighted by dark matter, slowing by 24% since it was created.
Public Health England found that two doses of the Pfizer and AstraZeneca vaccine could still keep patients with the Delta variant out of hospital - but both are now less able to stop infection in the first place.
A new study found that the Novavax vaccine was 93.2% effective against the Alpha variant - with no clarification about vaccine performance against the Delta variant.
